Abstract
This chapter is a summary of my keynote lecture given during the International Conference on Beneficial Microbes in Penang, Malaysia, from 27 to 29 May 2014. It describes the use of sophisticated dynamic, computer-controlled in vitro models of the gastrointestinal (GI) tract, developed by the Dutch Organization for Applied Scientific Research (TNO), nicknamed TIM. Among others, these have been used for determining and predicting survival of probiotics and the effects of prebiotics on the composition and activity of the gut microbiota. These sophisticated multicompartmental models closely mimic the dynamic conditions in the gastrointestinal (GI) tract and are therefore perfect tools to study mechanistically what happens in the GI tract. They can be used to study and optimize survival of probiotic strains and to screen for, e.g., an efficacious dose of prebiotics. Some examples on their use in optimizing probiotic survival, for instance, by combining them with prebiotics or developing a protective coating, are given. Also, the use of stable isotope-labeled substrates to trace metabolism of the gut microbiota as a tool to decipher what is going on in the colon is highlighted. Specific labeling of members of the microbiota and cross feeding are shown.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23(1):37–46. doi:10.1017/S0954422410000090, S0954422410000090 [pii]
Aguirre M, Jonkers DM, Troost FJ, Roeselers G, Venema K (2014) In vitro characterization of the impact of different substrates on metabolite production, energy extraction and composition of gut microbiota from lean and obese subjects. PLoS One 9(11), e113864. doi:10.1371/journal.pone.0113864, PONE-D-14-28411 [pii]
Binsl TW, De Graaf AA, Venema K, Heringa J, Maathuis A, De Waard P, Van Beek JH (2010) Measuring non-steady-state metabolic fluxes in starch-converting faecal microbiota in vitro. Benef Microbes 1(4):391–405. doi:10.3920/BM2010.0038, D57673QJ77444283 [pii]
Blatchford P, Ansell J, de Godoy MRC, Fahey G, Garcia-Mazcorro JF, Gibson GR, Goh YJ, Hotchkiss AT, Hutkins R, Lacroix C, Rastall RA, Reimer R, Schoterman M, van Sinderen D, Venema K, Whelan K (2014) Prebiotic mechanisms, functions and applications. Int J Probiotics Prebiotics 8:109–132
Bussolo CS, Roeselers G, Troost FJ, Jonkers DM, Koenen ME, Venema K (2014) Prebiotic effects of cassava bagasse in TNO’s in vitro model of the colon in lean versus obese microbiota. J Funct Foods 11:210–220
Costabile A, Kolida S, Klinder A, Gietl E, Bauerlein M, Frohberg C, Landschutze V, Gibson GR (2010) A double-blind, placebo-controlled, cross-over study to establish the bifidogenic effect of a very-long-chain inulin extracted from globe artichoke (Cynara scolymus) in healthy human subjects. Br J Nutr 104(7):1007–1017. doi:10.1017/S0007114510001571, S0007114510001571 [pii]
Coulier L, Timmermans J, Bas R, Van Den Dool R, Haaksman I, Klarenbeek B, Slaghek T, Van Dongen W (2009) In-depth characterization of prebiotic galacto-oligosaccharides by a combination of analytical techniques. J Agric Food Chem 57(18):8488–8495. doi:10.1021/jf902549e
de Graaf AA, Venema K (2008) Gaining insight into microbial physiology in the large intestine: a special role for stable isotopes. Adv Microb Physiol 53:73–168. doi:10.1016/S0065-2911(07)53002-X, S0065-2911(07)53002-X [pii]
de Graaf AA, Maathuis A, de Waard P, Deutz NE, Dijkema C, de Vos WM, Venema K (2010) Profiling human gut bacterial metabolism and its kinetics using [U-13C]glucose and NMR. NMR Biomed 23(1):2–12. doi:10.1002/nbm.1418
de Moreno de LeBlanc A, LeBlanc JG (2014) Effect of probiotic administration on the intestinal microbiota, current knowledge and potential applications. World J Gastroenterol 20(44):16518–16528. doi:10.3748/wjg.v20.i44.16518
Eeckhaut V, Ducatelle R, Sas B, Vermeire S, Van Immerseel F (2014) Progress towards butyrate-producing pharmabiotics: Butyricicoccus pullicaecorum capsule and efficacy in TNBS models in comparison with therapeutics. Gut 63(2):367. doi:10.1136/gutjnl-2013-305293, gutjnl-2013-305293 [pii]
Egert M, de Graaf AA, Smidt H, de Vos WM, Venema K (2006) Beyond diversity: functional microbiomics of the human colon. Trends Microbiol 14(2):86–91. doi:10.1016/j.tim.2005.12.007, S0966-842X(05)00338-0 [pii]
Egert M, de Graaf AA, Maathuis A, de Waard P, Plugge CM, Smidt H, Deutz NE, Dijkema C, de Vos WM, Venema K (2007) Identification of glucose-fermenting bacteria present in an in vitro model of the human intestine by RNA-stable isotope probing. FEMS Microbiol Ecol 60(1):126–135. doi:10.1111/j.1574-6941.2007.00281.x, FEM281 [pii]
Falony G, Lazidou K, Verschaeren A, Weckx S, Maes D, De Vuyst L (2009) In vitro kinetic analysis of fermentation of prebiotic inulin-type fructans by Bifidobacterium species reveals four different phenotypes. Appl Environ Microbiol 75(2):454–461. doi:10.1128/AEM.01488-08, AEM.01488-08 [pii]
FAO/WHO (2002) Guidelines for the evaluation of probiotics in food: joint FAO/WHO working group meeting, London, Ontario, Canada, 30 April–1 May 2002
Fassler C, Arrigoni E, Venema K, Brouns F, Amado R (2006) In vitro fermentability of differently digested resistant starch preparations. Mol Nutr Food Res 50(12):1220–1228. doi:10.1002/mnfr.200600106
Foolad N, Armstrong AW (2014) Prebiotics and probiotics: the prevention and reduction in severity of atopic dermatitis in children. Benef Microbes 5(2):151–160. doi:10.3920/BM2013.0034, 53H72643412K2P18 [pii]
Geurts L, Neyrinck AM, Delzenne NM, Knauf C, Cani PD (2014) Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 5(1):3–17. doi:10.3920/BM2012.0065, Y4415R00172218Q7 [pii]
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125(6):1401–1412
Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17(2):259–275. doi:10.1079/NRR200479, S0954422404000204 [pii]
Grabitske HA, Slavin JL (2009) Gastrointestinal effects of low-digestible carbohydrates. Crit Rev Food Sci Nutr 49(4):327–360. doi:10.1080/10408390802067126, 908821660 [pii]
He T, Venema K, Priebe MG, Welling GW, Brummer RJ, Vonk RJ (2008) The role of colonic metabolism in lactose intolerance. Eur J Clin Invest 38(8):541–547. doi:10.1111/j.1365-2362.2008.01966.x, ECI1966 [pii]
Henry SM (1996) Review: phenotyping for Lewis and secretor histo-blood group antigens. Immunohematology 12(2):51–61
Hertzler SR, Savaiano DA (1996) Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance. Am J Clin Nutr 64(2):232–236
Hoskins LC, Agustines M, McKee WB, Boulding ET, Kriaris M, Niedermeyer G (1985) Mucin degradation in human colon ecosystems. Isolation and properties of fecal strains that degrade ABH blood group antigens and oligosaccharides from mucin glycoproteins. J Clin Invest 75(3):944–953. doi:10.1172/JCI111795
Kemgang TS, Kapila S, Shanmugam VP, Kapila R (2014) Cross-talk between probiotic lactobacilli and host immune system. J Appl Microbiol 117(2):303–319. doi:10.1111/jam.12521
Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism shapes the human gut microbiota. Nat Rev Microbiol 10(5):323–335. doi:10.1038/nrmicro2746, nrmicro2746 [pii]
Kovatcheva-Datchary P, Egert M, Maathuis A, Rajilic-Stojanovic M, de Graaf AA, Smidt H, de Vos WM, Venema K (2009) Linking phylogenetic identities of bacteria to starch fermentation in an in vitro model of the large intestine by RNA-based stable isotope probing. Environ Microbiol 11(4):914–926. doi:10.1111/j.1462-2920.2008.01815.x, EMI1815 [pii]
Lau S (2014) Oral application of bacterial lysate in infancy diminishes the prevalence of atopic dermatitis in children at risk for atopy. Benef Microbes 5(2):147–149. doi:10.3920/BM2013.0007, 7V8L820P32562415 [pii]
Lied GA, Lillestol K, Lind R, Valeur J, Morken MH, Vaali K, Gregersen K, Florvaag E, Tangen T, Berstad A (2011) Perceived food hypersensitivity: a review of 10 years of interdisciplinary research at a reference center. Scand J Gastroenterol 46(10):1169–1178. doi:10.3109/00365521.2011.591428
López MG, Urías-Silvas JE (2007) Agave fructans as prebiotics. In: Norio S, Noureddine B, Shuichi O (eds) Recent advances in fructooligosaccharides research. Research Signpost, Kerala, India, pp 297–310
Maathuis A, Hoffman A, Evans A, Sanders L, Venema K (2009) The effect of the undigested fraction of maize products on the activity and composition of the microbiota determined in a dynamic in vitro model of the human proximal large intestine. J Am Coll Nutr 28(6):657–666, 28/6/657 [pii]
Maathuis AJ, van den Heuvel EG, Schoterman MH, Venema K (2012) Galacto-oligosaccharides have prebiotic activity in a dynamic in vitro colon model using a (13)C-labeling technique. J Nutr 142(7):1205–1212. doi:10.3945/jn.111.157420, jn.111.157420 [pii]
Mäkivuokko H, Wacklin P, Koenen ME, Laamanen K, Alakulppi N, Venema K, Mättö J (2012) Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition. Microb Ecol Health Dis 23:18578, http://dx.doi.org/18510.13402/mehd.v18523i18570.18578
Mansfield JA, Bergin SW, Cooper JR, Olsen CH (2014) Comparative probiotic strain efficacy in the prevention of eczema in infants and children: a systematic review and meta-analysis. Mil Med 179(6):580–592. doi:10.7205/MILMED-D-13-00546
Mardini HE, Grigorian AY (2014) Probiotic mix VSL#3 is effective adjunctive therapy for mild to moderately active ulcerative colitis: a meta-analysis. Inflamm Bowel Dis 20(9):1562–1567. doi:10.1097/MIB.0000000000000084
Marteau P, Minekus M, Havenaar R, Huis in’t Veld JH (1997) Survival of lactic acid bacteria in a dynamic model of the stomach and small intestine: validation and the effects of bile. J Dairy Sci 80(6):1031–1037. doi:10.3168/jds.S0022-0302(97)76027-2, S0022-0302(97)76027-2 [pii]
Martens EC, Koropatkin NM, Smith TJ, Gordon JI (2009) Complex glycan catabolism by the human gut microbiota: the Bacteroidetes Sus-like paradigm. J Biol Chem 284(37):24673–24677. doi:10.1074/jbc.R109.022848, R109.022848 [pii]
Martinez RC, Aynaou AE, Albrecht S, Schols HA, De Martinis EC, Zoetendal EG, Venema K, Saad SM, Smidt H (2011) In vitro evaluation of gastrointestinal survival of Lactobacillus amylovorus DSM 16698 alone and combined with galactooligosaccharides, milk and/or Bifidobacterium animalis subsp. lactis Bb-12. Int J Food Microbiol 149(2):152–158. doi:10.1016/j.ijfoodmicro.2011.06.010, S0168-1605(11)00347-3 [pii]
Martinez RC, Cardarelli HR, Borst W, Albrecht S, Schols H, Gutierrez OP, Maathuis AJ, de Melo Franco BD, De Martinis EC, Zoetendal EG, Venema K, Saad SM, Smidt H (2013) Effect of galactooligosaccharides and Bifidobacterium animalis Bb-12 on growth of Lactobacillus amylovorus DSM 16698, microbial community structure, and metabolite production in an in vitro colonic model set up with human or pig microbiota. FEMS Microbiol Ecol 84(1):110–123. doi:10.1111/1574-6941.12041
McNulty NP, Wu M, Erickson AR, Pan C, Erickson BK, Martens EC, Pudlo NA, Muegge BD, Henrissat B, Hettich RL, Gordon JI (2013) Effects of diet on resource utilization by a model human gut microbiota containing Bacteroides cellulosilyticus WH2, a symbiont with an extensive glycobiome. PLoS Biol 11(8), e1001637. doi:10.1371/journal.pbio.1001637, PBIOLOGY-D-13-01192 [pii]
Meijerink M, Mercenier A, Wells JM (2013) Challenges in translational research on probiotic lactobacilli: from in vitro assays to clinical trials. Benef Microbes 4(1):83–100. doi:10.3920/BM2012.0035, N4R08L76236U5022 [pii]
Mekkes MC, Weenen TC, Brummer RJ, Claassen E (2014) The development of probiotic treatment in obesity: a review. Benef Microbes 5(1):19–28. doi:10.3920/BM2012.0069, F7804HT630M53886 [pii]
Mills S, Stanton C, Fitzgerald GF, Ross RP (2011) Enhancing the stress responses of probiotics for a lifestyle from gut to product and back again. Microb Cell Fact 10(Suppl 1):S19. doi:10.1186/1475-2859-10-S1-S19, 1475-2859-10-S1-S19 [pii]
Minekus M (1998) Development and validation of a dynamic model of the gastrointestinal tract. Ph.D. thesis, Utrecht University, Utrecht
Minekus M, Marteau P, Havenaar R, Huis in’t Veld JHJ (1995) A multi compartmental dynamic computer-controlled model simulating the stomach and small intestine. Altern Lab Anim 23:197–209
Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, Alric M, Fonty G, Huis in’t Veld JH (1999) A computer-controlled system to simulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53(1):108–114
Miyazaki K, Masuoka N, Kano M, Iizuka R (2014) Bifidobacterium fermented milk and galacto-oligosaccharides lead to improved skin health by decreasing phenols production by gut microbiota. Benef Microbes 5(2):121–128. doi:10.3920/BM2012.0066, 14R282K2WR45KJ0N [pii]
Parker R (2014) Probiotic guideline for necrotizing enterocolitis prevention in very low-birth-weight neonates. Adv Neonatal Care 14(2):88–95. doi:10.1097/ANC.0000000000000043, 00149525-201404000-00006 [pii]
Pasman W, Wils D, Saniez MH, Kardinaal A (2006) Long-term gastrointestinal tolerance of NUTRIOSE FB in healthy men. Eur J Clin Nutr 60(8):1024–1034. doi:10.1038/sj.ejcn.1602418, 1602418 [pii]
Paton AW, Morona R, Paton JC (2012) Bioengineered microbes in disease therapy. Trends Mol Med 18(7):417–425. doi:10.1016/j.molmed.2012.05.006, S1471-4914(12)00082-2 [pii]
Ravcheev DA, Godzik A, Osterman AL, Rodionov DA (2013) Polysaccharides utilization in human gut bacterium Bacteroides thetaiotaomicron: comparative genomics reconstruction of metabolic and regulatory networks. BMC Genomics 14:873. doi:10.1186/1471-2164-14-873, 1471-2164-14-873 [pii]
Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR (2003) New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37(2):105–118
Remus DM, Kleerebezem M, Bron PA (2011) An intimate tete-a-tete - how probiotic lactobacilli communicate with the host. Eur J Pharmacol 668(Suppl 1):S33–S42. doi:10.1016/j.ejphar.2011.07.012
Sarbini SR, Kolida S, Naeye T, Einerhand A, Brison Y, Remaud-Simeon M, Monsan P, Gibson GR, Rastall RA (2011) In vitro fermentation of linear and alpha-1,2-branched dextrans by the human fecal microbiota. Appl Environ Microbiol 77(15):5307–5315. doi:10.1128/AEM.02568-10, AEM.02568-10 [pii]
Shanahan F, Dinan TG, Ross P, Hill C (2012) Probiotics in transition. Clin Gastroenterol Hepatol 10(11):1220–1224. doi:10.1016/j.cgh.2012.09.020, S1542-3565(12)01090-7 [pii]
Slavin J (2013) Fiber and prebiotics: mechanisms and health benefits. Nutrients 5(4):1417–1435. doi:10.3390/nu5041417, nu5041417 [pii]
Tsilingiri K, Rescigno M (2013) Postbiotics: what else? Benef Microbes 4(1):101–107. doi:10.3920/BM2012.0046, HM73405H773N76T7 [pii]
van Bergenhenegouwen J, Kraneveld AD, Rutten L, Kettelarij N, Garssen J, Vos AP (2014) Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis. PLoS One 9(2), e89121. doi:10.1371/journal.pone.0089121, PONE-D-13-39586 [pii]
Van Craeyveld V, Swennen K, Dornez E, Van de Wiele T, Marzorati M, Verstraete W, Delaedt Y, Onagbesan O, Decuypere E, Buyse J, De Ketelaere B, Broekaert WF, Delcour JA, Courtin CM (2008) Structurally different wheat-derived arabinoxylooligosaccharides have different prebiotic and fermentation properties in rats. J Nutr 138(12):2348–2355. doi:10.3945/jn.108.094367, 138/12/2348 [pii]
van Nuenen MHMC, Meyer PD, Venema K (2003) The effect of various inulins and Clostridium difficile on the metabolic activity of the human colonic microbiota in vitro. Microb Ecol Health Dis 15:137–144
van Nuenen MH, Venema K, van der Woude JC, Kuipers EJ (2004) The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease. Dig Dis Sci 49(3):485–491
Venema K (2012) Intestinal fermentation of lactose and prebiotic lactose derivatives, including human milk oligosaccharides. Int Dairy J 22(8):123–140
Venema K (2014) In vitro assessment of the bioactivity of food oligosaccharides. In: Moreno FJ, Sanz ML (eds) Food oligosaccharides: production, analysis and bioactivity. Wiley, Chichester, pp 219–237
Venema K (2015) Synbiotics – more than just the sum of pro- & prebiotics? In: Venema K, do Carmo AP (eds) Probiotics and prebiotics: current research and future trends. Caister Academic Press, Poole, pp 345–360
Venema K, Meijerink M (2015) Lactobacilli as probiotics: discovering new functional aspects and target sites. In: Venema K, Carmo AP (eds) Probiotics and prebiotics: current research and future trends. Caister Academic, Poole, pp 29–41
Venema K, van den Abbeele P (2013) Experimental models of the gut microbiome. Best Pract Res Clin Gastroenterol 27(1):115–126. doi:10.1016/j.bpg.2013.03.002, S1521-6918(13)00056-5 [pii]
Venema K, van Nuenen MHMC, van den Heuvel EG, Pool W, van der Vossen JMBM (2003) The effect of lactulose on the composition of the intestinal microbiota and short-chain fatty acid production in human volunteers and a computer-controlled model of the proximal large intestine. Microb Ecol Health Dis 15:94–105
Venema K, Vermunt SHF, Brink EJ (2005) D-Tagatose increases butyrate production by the colonic microbiota in healthy men and women. Microb Ecol Health Dis 17:47–57
Venema K, Havenaar R, Minekus M (2009) Improving in vitro simulation of the stomach and intestines. In: McClements DJ, Decker E (eds) Designing functional foods: measuring and controlling food structure breakdown and nutrient absorption. Woodhead Publishing, Cambridge, pp 314–339
Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S, Coulson S (2014) The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures. Pharmaceuticals (Basel) 7(9):954–989. doi:10.3390/ph7090954, ph7090954 [pii]
Wells JM, Rossi O, Meijerink M, van Baarlen P (2011) Epithelial crosstalk at the microbiota-mucosal interface. Proc Natl Acad Sci USA 108(Suppl 1):4607–4614. doi:10.1073/pnas.1000092107
Yasutake K, Kohjima M, Nakamuta M, Kotoh K, Murata Y, Enjoji M (2014) Probiotic nutrition therapy for nonalcoholic fatty liver disease. Fukuoka Igaku Zasshi 105(2):42–47
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Venema, K. (2015). Health Effects of Pro- and Prebiotics: Utilization of Sophisticated In Vitro Tools. In: Liong, MT. (eds) Beneficial Microorganisms in Medical and Health Applications. Microbiology Monographs, vol 28. Springer, Cham. https://doi.org/10.1007/978-3-319-23213-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-23213-3_1
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-23212-6
Online ISBN: 978-3-319-23213-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)